Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.
Wadhera, Rishi K, Robert A Kyle, Dirk R Larson, Angela Dispenzieri, Shaji Kumar, Hillard M Lazarus, and Vincent Rajkumar. 2011. “Incidence, Clinical Course, and Prognosis of Secondary Monoclonal Gammopathy of Undetermined Significance in Patients With Multiple Myeloma.”. Blood 118 (11): 2985-7.